Global Swine Healthcare Market Size study, by Product (Diagnostics Tests, and Therapeutics), by Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), and Regional Forecasts 2022-2028

Global Swine Healthcare Market Size study, by Product (Diagnostics Tests, and Therapeutics), by Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), and Regional Forecasts 2022-2028

Global Swine Healthcare Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2028. The global swine health business is gaining traction as a result of high demand for pig health products. Swine health is linked to pig diseases, and medicines are being developed to prevent abnormalities or misalignment. Pigs develop diseases such as congenital abnormalities and reproductive disorders as a result of breeding. As a result, several governmental organizations are taking major steps by developing initiatives aimed at improving or protecting swine health, which also helps to reduce the impact of swine disease on humans. Further, the market is driven by key factors such as increasing demand for livestock products and rising cases of swine infections or swine flu. According to the US Department of Agriculture's August 2019 report, US exports average 20 percent of commercial pork worldwide. Also, the US is the world's third-largest producer and consumer of pork and pork products, and in recent years, implying that demand for swine healthcare products will rise. However, high cost associated with Swine Health, especially in the developing countries impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Swine Healthcare Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market shares in terms of revenue, owing to the positive factors such as increasing government imitative in animal welfare and rise in pork eating population. However, Asia Pacific and Latin America are expected to be the fastest growing regions, owing to the increasing prevalence of animal disease across the regions.

Major market players included in this report are:
Merck & Co Inc.
C. Boehringer Ingelheim GmBH
Zoetis Animal Healthcare
Huvepharma
Vetoquinol SA
IDEXX Laboratories Inc.
Ceva Animal Health Inc.
Virbac
Phibro Animal Health
Elanco

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Diagnostics Tests
Therapeutics
By Disease:
Exudative dermatitis (greasy pig disease)
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Swine Healthcare Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Merck & Co Inc.
C. Boehringer Ingelheim GmBH
Zoetis Animal Healthcare
Huvepharma
Vetoquinol SA
IDEXX Laboratories Inc.
Ceva Animal Health Inc.
Virbac
Phibro Animal Health
Elanco

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.